These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stevens-Johnson syndrome and toxic epidermal necrolysis: what do we know? Tartarone A; Lerose R Ther Drug Monit; 2010 Dec; 32(6):669-72. PubMed ID: 20844465 [TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. Sane SP; Bhatt AD J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928 [TBL] [Abstract][Full Text] [Related]
5. [Stevens-Johnson syndrome and toxic epidermal necrolysis following intake of sulfonamides]. Aberer W; Stingl G; Wolff K Hautarzt; 1982 Sep; 33(9):484-90. PubMed ID: 7174320 [TBL] [Abstract][Full Text] [Related]
6. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
7. Malfeasance on an industrial scale. Prescrire Int; 2013 Feb; 22(135):32. PubMed ID: 23444493 [No Abstract] [Full Text] [Related]
9. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Porteous DM; Berger TG Arch Dermatol; 1991 May; 127(5):740-1. PubMed ID: 1827245 [No Abstract] [Full Text] [Related]
10. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis]. van der Meer JB Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761 [No Abstract] [Full Text] [Related]
11. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations]. Halevy S Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173 [TBL] [Abstract][Full Text] [Related]
12. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study. Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140 [TBL] [Abstract][Full Text] [Related]
13. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195 [TBL] [Abstract][Full Text] [Related]
14. Severe adverse cutaneous reactions to drugs. Roujeau JC; Stern RS N Engl J Med; 1994 Nov; 331(19):1272-85. PubMed ID: 7794310 [No Abstract] [Full Text] [Related]
16. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Gerull R; Nelle M; Schaible T Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399 [TBL] [Abstract][Full Text] [Related]